Agile Therapeutics, Inc.

Q4 2018 13F Holders

Symbol
AGRX
CUSIP
00847L100
Type
Equity
Class
COM
Num filings
30
Total reported value, excl. options
$5.60 M
Manager Report Date Value ($000) Shares Option Type